M. V. Williams, N. D. James, E. T. Summers, A. Barrett and D. V. Ash, “On Behalf of the Audit Sub-Committee, Faculty of Clinical Oncology and the Royal College of Radiologists National Survey of Radiotherapy Fractionation Practice in 2003,” Clinical Oncology (Royal College of Radiologists), Vol. 18, No. 1, 2006, pp. 3-14. doi:10.1016/j.clon.2005.10.002

has been cited by the following article:

• TITLE: Assessing Patient Outcomes after Palliative Radiotherapy Using IG-IMRT

  AUTHORS: Rajiv Samant, Michael Scopazzi, Kathy Carty

  KEYWORDS: Radiotherapy; Palliation; Symptom Improvement; IG-IMRT

  JOURNAL NAME: Journal of Cancer Therapy, Vol.3 No.6, December 6, 2012

  ABSTRACT: Purpose: To assess clinical outcomes after using IG-IMRT for palliation among patients with advanced cancers. Methods: Patients with advanced and/or metastatic cancers were treated on our Tomo-PAL (Tomotherapy?-Planning and Administration Linked) protocol using helical TomoTherapy? and evaluated to assess clinical efficacy of treatment as well as to assess side effects. Results: A total of 40 patients were treated to 40 sites from Feb 2007 to May 2009. There were 25 men and 15 women with a median age of 70 years (range 16 - 94). Pain and bleeding were the most common symptoms being palliated (80% and 12.5% respectively). The dose prescribed ranged from 5 - 25 Gy in 1 - 5 fractions. A qualitative improvement in symptoms was documented in 82% of patients (75% partial relief and 7% complete relief) and major side effects were not encountered. Conclusions: IG-IMRT can be used for palliation and produces response rates that compare favourably with those reported in the published literature.